BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6806261)

  • 1. Mechanisms of ligand binding by monoclonal anti-fluorescyl antibodies.
    Kranz DM; Herron JN; Voss EW
    J Biol Chem; 1982 Jun; 257(12):6987-95. PubMed ID: 6806261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics and mechanism of deuterium oxide-induced fluorescence enhancement of fluorescyl ligand bound to specific heterogeneous and homogeneous antibodies.
    Kranz DM; Herron JN; Giannis DE; Voss EW
    J Biol Chem; 1981 May; 256(9):4433-8. PubMed ID: 7217089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Idiotypic analysis of monoclonal anti-fluorescyl antibodies: localization and characterization of idiotypic determinants.
    Kranz DM; Voss EW
    Mol Immunol; 1983 Dec; 20(12):1301-12. PubMed ID: 6197634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solvent perturbation of the fluorescence of fluorescyl ligand bound to specific antibody. Fluorescence enhancement of antibody bound fluorescein (hapten) in deuterium oxide.
    Voss EW; Watt RM; Weber G
    Mol Immunol; 1980 Apr; 17(4):505-17. PubMed ID: 7393237
    [No Abstract]   [Full Text] [Related]  

  • 5. Idiotypic cross-reactivity of low-affinity anti-fluorescyl monoclonal antibodies.
    Reinitz DM; Voss EW
    Mol Immunol; 1984 Sep; 21(9):775-84. PubMed ID: 6434941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of heterogeneous dissociation kinetics in polyclonal populations of rabbit anti-fluorescyl-IgG antibodies.
    Herron JN; Voss EW
    Mol Immunol; 1983 Dec; 20(12):1323-32. PubMed ID: 6656777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of secondary forces on the ligand binding properties and variable domain conformations of a monoclonal anti-fluorescyl antibody.
    Mummert ME; Voss EW
    Mol Immunol; 1996 Sep; 33(13):1067-77. PubMed ID: 9010246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative properties of the single chain antibody and Fv derivatives of mAb 4-4-20. Relationship between interdomain interactions and the high affinity for fluorescein ligand.
    Mallender WD; Carrero J; Voss EW
    J Biol Chem; 1996 Mar; 271(10):5338-46. PubMed ID: 8621386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural properties of an anti-fluorescein monoclonal IgM cryoglobulin.
    Dombrink-Kurtzman MA; Lacy MJ; Voss EW
    Mol Immunol; 1989 Aug; 26(8):779-87. PubMed ID: 2811871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyclonal antibodies specific for liganded active site (metatype) of a high affinity anti-hapten monoclonal antibody.
    Voss EW; Miklasz SD; Petrossian A; Dombrink-Kurtzman MA
    Mol Immunol; 1988 Aug; 25(8):751-9. PubMed ID: 3185570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryoprecipitation properties of a high-affinity monoclonal IgM anti-fluorescyl antibody.
    Dombrink-Kurtzman MA; Voss EW
    Mol Immunol; 1988 Dec; 25(12):1309-20. PubMed ID: 3237215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand binding to anti-fluorescyl antibodies: stability of the antigen binding site.
    Müller JD; Nienhaus GU; Tetin SY; Voss EW
    Biochemistry; 1994 May; 33(20):6221-7. PubMed ID: 8193136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of interactions involving anti-metatype antibodies and immune complexes.
    Weidner KM; Voss EW
    Mol Immunol; 1992 Mar; 29(3):303-12. PubMed ID: 1372954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular stabilization effects of interactions between anti-metatype antibodies and liganded antibody.
    Weidner KM; Denzin LK; Voss EW
    J Biol Chem; 1992 May; 267(15):10281-8. PubMed ID: 1587817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inter-relationship between immunoglobulin idiotype and metatype.
    Voss EW; Dombrink-Kurtzman MA; Ballard DW
    Mol Immunol; 1989 Oct; 26(10):971-7. PubMed ID: 2480517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative binding properties of fluorescein and 9-hydroxyphenylfluoron (HPF) with murine monoclonal anti-fluorescein antibodies.
    Bedzyk WD; Swindlehurst CA; Voss EW
    Biochim Biophys Acta; 1992 Feb; 1119(1):27-34. PubMed ID: 1540631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of defined idiotypes throughout the BALB/c anti-fluorescyl antibody response: affinity and idiotype analyses of heterogeneous antibodies.
    Kranz DM; Ballard DW; Voss EW
    Mol Immunol; 1983 Dec; 20(12):1313-22. PubMed ID: 6197635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restricted reassociation of heavy and light chains from hapten-specific monoclonal antibodies.
    Kranz DM; Voss EW
    Proc Natl Acad Sci U S A; 1981 Sep; 78(9):5807-11. PubMed ID: 6795637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thermodynamic properties of ligand binding by monoclonal anti-fluorescyl antibodies.
    Herron JN; Kranz DM; Jameson DM; Voss EW
    Biochemistry; 1986 Aug; 25(16):4602-9. PubMed ID: 3768301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-affinity rat anti-fluorescein monoclonal antibody with unique fine specificity properties including differential recognition of dynamic ligand analogues.
    Miklasz SD; Gulliver GA; Voss EW
    J Mol Recognit; 1995; 8(4):258-69. PubMed ID: 8588943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.